Healthcare
Mayfair Clinical Education & Research Centre P.Ltd.
Established in 2004, Mayfair Clinical Education & Research Centre, conducts Clinical trials Phase I, II & III, where in studies are involved in Healthy human volunteers (BE/BA studies), Infants and neonates, Small number of patients, Patients in hospitals & Clinical trials Phase II to Phase III studies in patients for various pharmaceutical companies in India and abroad.
a Private Limited co. originally incorporated on 16.12.87. is registered under the companies Act 1956. Its registrations No. is 04-10195 Dtd.18.07.2003. The Company is ISO 9001 company. It possesses Licence issued by Dy. Director Drug control and joint director drug control D.G.H.S. New Delhi.
The registered office is situated at 6, Aditya Bunglow, Opp.”SAL” Hospital, Thaltej, Ahmedabad. The objects of the company is to carry out analytical testing and research laboratories, to carry out operations of Bio- Availability (BA) and Bio-Equivalence (BE) studies on healthy human volunteers, clinical trials formulations and new molecules developments through pilot plant besides various research work of medicines, pharmaceuticals, and experimental workshops for scientific and technical research.
"Mayfair" has created fully equipped state-of-the-Art infra-structure facilities with scientific and technological equipments costing around Rs.436.33Lacs, having installed capacity of 42 beds of international standards for healthy human volunteers for upgrading own reports and processes. The Research Centre is located at Mohan Mill Compound, Ghodbunder Road,Thane. Highly qualified and experienced team conducts all the studies.
The Uniqueness of the Centre is:
• Conducting the Clinical studies in all facts under one umbrella,
• Imparting education in emerging fields,
• Conducting research in Pharmaceutical and Medical Sciences.
Documentation
– Excellent documentation covers all aspects
Regulatory Compliance :
The studies are conducted under GCP and GLP guidelines, and religiously following USFDS, ICH and WHO guidelines after compliance with regulatory requirements of various countries
Mission
Mayfair Clinical Education & research Centre, shall fulfill, its responsibility religiously to customers by conducting studies with full integrity. It strives for upgrading its reports/processes through appropriate technology. To facilitate this, the centre possesses the State-of-the-art scientific & technological inputs in our research and education activities
Vision
To find place in front line and be a leader in clinical studies in India.
Services Offered
Right Protocol to give desired results Right SOP for systems On time delivery of reports with strong emphasis on our values namely "Transparency, Excellence, Integrity, Sincerity, Innovativeness, Punctuality & Accountability"
The Facilities
• Pre-Clinical- Associate at Pune
• Clinical for BE/BA – 42 beds facility
• Clinical Trials Phase II to phase IV under expert guidance of
Dr.(Mrs.)M.U.Shah monitored by CRA in hospitals.
Education
State-of-the-art auditorium & conference room with audio-visual equipments viz. LCD projector, 35mm slide projector and OHP.
Research
The laboratory with all important available instruments and equipments. Library facilities, office automation for literature and Patent search and full documentation.
Analytical
• Validated and 21 CFR part 11 compliant LCMS-MS and HPLCs with Electrochemical, PDA, Fluorescent & UV-Vis detectors
• GC with ECD & NPD
• Complete HPTLC system with linomat applicator,
• 6-station dissolution testers with spectrophotometers,
• Zymark’s solid Phase extraction and evaporation unit for purification of plasma samples.
Expansion Plan
Research & Development in Pharmaceutical formulations and New Drug Delivery System (NDDS).
Stability studies as per ICH guidelines
Isolation of markers and their use in standardization of Herbals
Conduct ‘value addition’ courses for students, teachers and medical & allied fraternity under Education program.
THUS, MAYFAIR OFFERS A COMPLETE SOLUTION TO FORMULATION AND CLINICAL PROBLEMS FOR INVESTIGATIONAL NEW DRUGS (IND) & ABBREVIATED NEW DRUG APPLICATIONS (ANDA), GENERICS, BOTANICALS AND HERBALS WITH RESPECT TO CLINICAL STUDIES AND COMPLETE STANDARDIZATION
